High discordance rate in assessing sentinel node positivity in cutaneous melanoma: Expert review may reduce unjustified adjuvant treatment

Introduction: Identification of sentinel node (SN) metastases can set the adjuvant systemic therapy indication for patients with stage III melanoma. Studies re-evaluating the diagnosis of initially positive SN biopsies are scarce. Materials and methods: Dutch patients with melanoma who underwent SN biopsy between 2003 and 2014 were selected from PALGA, the Dutch Pathology Registry. Histopathological slides of SN-positive patients were retrieved for review. A random sample was reassessed by an expert melanoma pathologist. Recurrence-free survival (RFS) of patients who were misclassified (false-... Mehr ...

Verfasser: El Sharouni, Mary Ann
Laeijendecker, Annelien E.
Suijkerbuijk, Karijn PM
Witkamp, Arjen J.
Sigurdsson, Vigfús
van Diest, Paul J.
van Gils, Carla H.
Blokx, Willeke AM
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Schlagwörter: Adjuvant therapy / Melanoma / Nodal nevus / Pathology / Sentinel / Predictive Value of Tests / Humans / Middle Aged / Male / Unnecessary Procedures / False Positive Reactions / Patient Selection / Netherlands / Clinical Decision-Making / Adult / Female / Registries / Sentinel Lymph Node/pathology / Retrospective Studies / Melanoma/secondary / Reproducibility of Results / Treatment Outcome / Combined Modality Therapy / Skin Neoplasms/pathology / Aged / Sentinel Lymph Node Biopsy / Neoplasm Staging / Observer Variation / Oncology / Cancer Research / Journal Article
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27612672
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dspace.library.uu.nl/handle/1874/442620